Fundraising FoxArkin Capital — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
BiotechBoston, US
David Donabedian(Executive Officer, Director)inRobert Hadfield(Executive Officer)inJohn McCabe(Executive Officer)in
BoardChristoph Westphal(Director)Ming Cheah(Director)inRaymond Camahort(Director)
Co-investorsDCVC (Data Collective)DCVC BioLongwood FundNovo Holdings
Israeli company developing a novel superconducting quantum processor architecture with an 'architecture-first' approach enabling fault-tolerant, scalable systems for millions of qubits.
Co-investorsEarth and beyond venturesIneffable VenturesQ FundQbeat VenturesRhodiumSurround Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.